Clinical trials - Press Releases

Date	Title	Company
31-Oct-2025	Peptide Synthesis Market to Surpass USD 1,066.7 Million by 2032, Driven by Demand for Peptide-Based Therapeutics and Personalized Medicine	Ameco Research
30-Oct-2025	Global Antinuclear Antibody Test Market to Reach USD 5.07 Billion by 2033, Forecasts FutureWise Research	FutureWise Research
30-Oct-2025	AC Immune Appoints Renowned Neurologist Catherine Mummery as Chair of Clinical Advisory Board	AC Immune
24-Oct-2025	Personalized Medicine Biomarkers Market 2025–2033: Trends, Growth Drivers, and Market Size Forecast to USD 72.06 Billion	Acumen Research And Consulting
23-Oct-2025	Orion and Abzena Announce Exclusive Commercial License for Abzena’s Antibody	Abzena
23-Oct-2025	Medherant Announces Positive Results for Initial Phase 1 Clinical Trial of Testosterone Patch for Women	Medherant
23-Oct-2025	Oximio Welcomes Bay Area Research Logistics in Canada to the Family, Expanding Global Reach and Service Capabilities	Oximio
22-Oct-2025	Olympus: "Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India" Selected for METI's FY2024 Supplementary "Global South Future-Oriented Co-Creation Subsidy Program (Small-Scale Demonstration / Feasibility Study Project)"	Olympus Corp
21-Oct-2025	Subcutaneous RYBREVANT®▼(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer	Johnson & Johnson
21-Oct-2025	selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease	selectION, Inc.
20-Oct-2025	ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors	ImmunOs Therapeutics
17-Oct-2025	STEMart Launches Advanced Bacterial Reverse Mutation Test (Ames) Service to Accelerate Medical Device Safety Assessment	STEMart
17-Oct-2025	CD Bioparticles Launches Advanced Tumor Organoid & CAF Co-culture Service to Accelerate Cancer Research	CD Bioparticles
17-Oct-2025	Creative Diagnostics Introduces OGN™ Tumor-derived Organoid Culture Kits to Advance Cancer Research	Creative Diagnostics
16-Oct-2025	LLRI – Learning Labb Research Institute: Your Path to Healthcare & Life-Sciences Careers	Learning Labb Research Institute
15-Oct-2025	Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14	Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14
14-Oct-2025	Almac Trial Coordinator Launched in $48 Million Investment to Advance Integrated eClinical Technologies	Almac
13-Oct-2025	New medical writing service provider QInscribe reduces the time to generate a draft clinical study report (CSR) by 90% with generative AI solution	QInscribe
09-Oct-2025	New GCP Training Aligned with ICH E6(R3) from Pharma Lessons	Pharma Lessons
09-Oct-2025	FDA Approves Libtayo as First Immunotherapy for Adjuvant Treatment of CSCC	Regeneron Pharmaceuticals, Inc.